Advertisement

Sunovion Pharmaceuticals, which is owned by Japanese drug maker Dainippon Sumitomo Pharma, confirmed last week that it will lay off an undisclosed number of sales representatives that are responsible for selling the company’s asthma drugs. The number of the layoffs was earlier reported to be near 300.

SOURCE

Advertisement
Advertisement